Respiratory Syncytial Virus Vaccines: Are We Making Progress?
No abstract available
Publication date: Available online 17 October 2019Source: Pathology - Research and PracticeAuthor(s): Jia Yang, Junjie Shangguan, Aydin Eresen, Yu Lia, Jian Wang, Zhuoli ZhangAbstractDespite significant advances over the past decades of research, pancreatic cancer (PC) continues to have the worst 5-year survival of any malignancy. Dendritic cells (DCs) are the most potent professional antigen-presenting cells and are involved in the induction and regulation of antitumor immune responses. DC-based immunotherapy has been used in clinical trials for PC. Although safety, efficacy, and immune activation were reported in patient...
ConclusionsSOPs may provide a good starting point for increasing adult immunization coverage rates. Using additional interventions, quality-based metrics, or incentives could lead to sustained adult immunization prioritization.
The exemption rate for one or more required vaccines was 2.5% in the 2018-19 school year, up from 2.3% in the previous year, and 2.1% in the 2016-17 school year, according to the U.S. Centers for Disease Control and Prevention, CNN reported Friday.
The so-called Merck vaccine was approved his afternoon and is likely to get a full marketing licence from the European Commission within a few weeks.
The world's first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a "triumph for public health" that would save many lives.
Condition: To Assess the Safety and Tolerability of MVA-BN-WEV Vaccine in Healthy Adult Subjects Intervention: Biological: MVA-BN-WEV Sponsors: Bavarian Nordic; Joint Project Manager for Chemical, Biological, Radiation, and Nuclear Medical (JPM CBRN Medical) Recruiting
Conditions: Human Papillomavirus Type 16; Cervical Intraepithelial Neoplasia Grade II; Cervical Intraepithelial Neoplasia, Grade III Intervention: Drug: pNGVL4aCRTE6E7L2 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI) Not yet recruiting
There's an explanation for why the vaccine makes your arm sore. But there are also ways to manage the pain.
World Health Organization calls European recommendation for an Ebola vaccine originally developed in Canada a major milestone.
FRIDAY, Oct. 18, 2019 -- For the 2018 to 2019 school year, coverage was 94.7 percent for two doses of the measles, mumps, and rubella (MMR) vaccine, according to research published in the Oct. 18 issue of the U.S. Centers for Disease Control and...